MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth
The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS’ leadership in data-focused clinical research services. CANTON, Michigan – June 28, 2022 – MMS Holdings Inc. (“MMS” or the “Company”), a leading data-focused...
Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings
On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted...
Attending the American Chemical Society Central Regional Meeting 2022 – Key Highlights
I attended the American Chemical Society (ACS) Central Regional Meeting - CERM 2022 in person, hosted at Eastern Michigan University in Ypsilanti, Michigan, June 7-10th Attendance was still adversely affected by understandable caution around COVID-19 and flight...
Medical Writing Trends in the Era of COVID-19 and Remote Work: Enhancing Virtual Relationships and Emphasizing Emotional Intelligence
Being a medical writer entails creating well-structured scientific materials like clinical research papers, content for healthcare websites, periodicals, journals, and more. The medical sciences industry is growing, driving new demand for medical writers in the...
MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors
CANTON, MI (6/7/2022) – MMS Holdings, a data-focused Contract Research Organization (CRO), is pleased to announce a strategic partnership with Medidata, a Dassault Systèmes company, to provide clients a full range of solutions for clinical data management (CDM) and...
Attending the 2022 PHUSE US Connect: A Data Scientist’s Experience
Attending the 2022 PHUSE US Connect in Atlanta was similar to attending a concert for one of your favorite music artists. Technology does a fantastic job trying to virtually mimic in-person interaction, whether it’s a virtual meeting with your peers or watching a...
MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials
CANTON, Mich. (05/24/2022) – MMS Holdings Inc. (MMS) – an award-winning, data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services....
A Message from our Founder on International Clinical Trials Day
At MMS, we take great pride in our work as a data CRO and hence May 20th has a special significance for us as International Clinical Trials Day. Clinical trials are the backbone of drug development and allow our industry to look at the efficacy and safety of...
Key Takeaways from FDA GCP Inspection Trends in 2021
The FDA oversees clinical trials to ensure they are designed, conducted, analyzed and reported according to federal law and good clinical practice (GCP) regulations. The FDA’s Office of Regulatory Affairs (ORA) is the lead office for inspections and enforcement. ORA...